The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

The ASX200 has been up 0.25% at 7,970 points.

The Aussie market received mixed messages from Wall Street overnight, with the Dow Jones inching higher, but the S&P 500 chalking up a loss.

Back home, Information Technology surged 1.6% today, followed closely by Real Estate 1.55% and Financials up 1%.

The Energy sector has crumbled, down around 4.2%, after the Oil price hit a 12 month low.

Company News

Next DC (ASX:NXT) has been up more than 8%, after the $24 billion acquisition of AirTrunk by Blackstone prompted investors to pivot to risk on for data centres.

Next DC has been trading at $17.38.

Woodside (ASX:WDS) has been pummeled this morning, down around 6.8%. The catalyst for the sell off has been oil prices hitting a 12 month low and a downgrade by Citi from Neutral to Sell.

Woodside has been $25.00 in early afternoon trade.

Woodside wasn’t the only well-known name taking a bruising on Thursday; Chris Ellison’s Mineral Resources (ASX:MIN) was down around 7.6% in early afternoon trades. 

The company, exposed to both lithium and iron ore, continues to struggle retaining investor confidence as the price of commodities remain under pressure.

Iron ore is currently at $91 per tonne on the Singapore Exchange.

Mineral Resources has been trading at $31.50.

More From The Market Online
Organised crime concept

Panic, paranoia, and gangland politics: HotCopper users react to Dubber’s missing $26M

HotCopper users have reacted to overnight reports Dubber has seen $26M disappear from its coffers due…
The Market Online Video

ASX Market Update: Bourse nears record approaching week’s end | November 22, 2024

The bourse is near record territory to close out the week on the back of a…
Image of four gold necklaces

Sales growth pushes Lovisa’s fortunes (and shares) upwards

Lovisa Holdings Ltd has seen its shares rise more than 2% following a sales update, and…
Image of eyes in closeup

Scientific conference spotlights PYC’s work on blindness disease treatment

PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat…